MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)

Abstract

MET status is highly heterogeneous among different nsNSCLC tumor areas, hindering adequate patient selection for MET-targeted therapies. MET cytoplasmic staining and vimentin might represent surrogate markers for MET activation.